Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02145871 · ClinicalTrials.gov registry record · Phase 3
A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy
A Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 282
- Enrollment target
NCT02145871: Completed Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02145871 is a Phase 3 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 282 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02145871, a Phase 3 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 282 participants
- Enrollment target
Study Summary
The purpose of this study is to help us learn what is the best amount of fluid to give to patients during bladder surgery in order to avoid delayed bowel function after surgery, which could prolong hospital stay.
Interventions
- OTHER standard fluid management
- OTHER fluid management guided by the EV1000
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 282 participants |
| Start Date | 2014-05-21 |
| Est. Completion | 2024-03-14 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02145871
The ClinicalTrials.gov registry entry for NCT02145871 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 282 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which standard fluid management is the first listed.
NCT02145871 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02145871 about?
NCT02145871 is a clinical study titled "A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy". The purpose of this study is to help us learn what is the best amount of fluid to give to patients during bladder surgery in order to avoid delayed bowel function after surgery, which could prolong hospital stay.
What is the current status of trial NCT02145871?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 282 participants. The study started on 2014-05-21. Estimated completion is 2024-03-14.
What interventions are being tested in trial NCT02145871?
The interventions under investigation include: standard fluid management (OTHER), fluid management guided by the EV1000 (OTHER).
Who is sponsoring clinical trial NCT02145871?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.